● In view of fundamental criteria, the company is among low performers as far as mid or long-term investment strategy is concerned.
● For a short-term investment strategy, the company has poor fundamentals.
Strengths
● The stock, which is currently worth 2020 to 0.76 times its sales, is clearly overvalued in comparison with peers.
● The stock is in a well-established, long-term rising trend above the technical support level at 4.62 EUR
Weaknesses
● The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.
● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
● Low profitability weakens the company.
● The group shows a rather high level of debt in proportion to its EBITDA.
● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
● For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
● For the past year, analysts have significantly revised downwards their profit estimates.
● The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.